Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
about
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.DNA and histone deacetylases as targets for neuroblastoma treatment.Genetic polymorphisms of CYP2D6 oxidation in patients with systemic lupus erythematosus.Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancerSeverely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer managementPhase I and Phase II enzyme polymorphisms and childhood cancer.Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profileInterindividual variability of methadone response: impact of genetic polymorphism.Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line.CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.Clinically-relevant anticancer-antidepressant drug interactions.Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome.6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes.Association of cytochrome P450 2C9 polymorphism with locally advanced head and neck squamous cell carcinoma and response to concurrent cisplatin-based radical chemoradiationGenetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population."Drugs on oxygen": an update and perspective on the role of cytochrome P450 testing in pharmacology.CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen
P2860
Q34018308-82827C01-5E5B-4B80-8E26-BF61E81936C2Q34320121-F6787D28-774B-4B40-9434-8838026BFC03Q35674307-5C5D7E83-0154-49F4-B23C-73778F206762Q35749331-CD29F1C9-C131-46DB-ABDD-6B85A537B1AAQ36359764-D6FC5F71-F328-4E5A-8C64-A9CB4609863FQ36441485-D5774372-8455-44F0-8E98-087D56A58B91Q36668333-1C5B74D6-B2AB-493E-8067-F09E42090D7AQ37063883-64C64F2A-4AFD-44E4-8052-603E5A5B2306Q37142009-83835C67-D2BD-4276-8741-99B2AB1AC07DQ37271799-B1439A98-53C6-4FDE-BF42-8B77964ABC14Q37326678-958D4BF4-7171-4340-B3EB-39A4F3DFB6D5Q37406272-2D31A198-4BAE-4C7D-B4F2-E40326FB6A53Q37685527-EEF7B88C-D807-4A85-805E-AE6A7D199580Q37970709-E650828D-F3D0-4677-B8C8-355E91FAA742Q39701132-48146697-1324-4BE9-8F0A-4D9645E3C349Q42212451-F77939E5-3EF9-4767-BC67-68F026292F74Q42794014-3AAC8342-6EAB-45CA-A610-7192A9A2533EQ43879115-5941DE7B-BB00-4412-B192-99722EEE9EFCQ46175794-596AB3D4-B1D0-479F-AA01-F0EDAE3E6EDEQ51557998-A61C0038-0478-4D07-B266-CCD21D393DF4Q57786811-15F4B829-69B4-4362-91DB-071D70554B4E
P2860
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@ast
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@en
type
label
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@ast
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@en
prefLabel
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@ast
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@en
P2860
P1476
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
@en
P2093
Ron H N van Schaik
P2860
P2888
P304
P356
10.1007/S10637-005-4019-1
P577
2005-12-01T00:00:00Z